Use of Chinese medicine among survivors of nasopharyngeal carcinoma in Taiwan: A population-based study

Integrative Cancer Therapies

Volumn 11, Issue 3, 2012, Pages 221-231

  Chien, Chun Ru ^a,b,c   Su, Shan Yu ^a,b   Cohen, Lorenzo ^c   Lin, Hsiang Wen ^a,b   Lee, Richard Tsong ^c   Shih, Ya Chen Tina ^c,d  

^a China Medical University Hospital   (China)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

complementary and alternative medicine; continuing care phase; nasopharyngeal carcinoma; survivorship; Taiwan; traditional Chinese medicine

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; AMBULATORY CARE; ARTICLE; CANCER SURVIVOR; CHINESE MEDICINE; CLINICAL FEATURE; COMMON COLD; COMORBIDITY; CONTROLLED STUDY; COUGHING; FEMALE; HEAD AND NECK CANCER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LOW BACK PAIN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYOSITIS; NASOPHARYNX CARCINOMA; NEURALGIA; NEURITIS; OUTCOME ASSESSMENT; POLYDIPSIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RADICULITIS; SOCIOECONOMICS; TAIWAN; TINNITUS;

EID: 84860514683     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735411403308     Document Type: Article

References (57)

1. Jeyakumar A, Brickman TM, Doerr T. Review of nasopharyngeal carcinoma. Ear Nose Throat J. 2006 ; 85: 168-170
2. Taiwan Cancer Registry. http://tcr.cph.ntu.edu.tw/uploadimages/Leading- 10.pdf. Accessed July 24, 2010.
3. Lee N, Puri DR, Blanco AI, Chao KS. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck. 2007 ; 29: 387-400 (Pubitemid 46623504)
4. National Center for Complementary and Alternative Medicine Web site. http://nccam.nih.gov/health/. Accessed July 24, 2010.
5. House of Lords. Complementary and alternative medicine: science and technology, sixth report. http://www.parliament.the-stationery-office.co.uk/pa/ ld199900/ldselect/ldsctech/123/12301.htm. Accessed July 24, 2010.
6. Munshi A, Ni LH, Tiwana MS. Complementary and alternative medicine in present day oncology care: promises and pitfalls. Jpn J Clin Oncol. 2008 ; 38: 512-520
7. Wesa K, Gubili J, Cassileth B. Integrative oncology: complementary therapies for cancer survivors. Hematol Oncol Clin North Am. 2008 ; 22: 343-353 (Pubitemid 351452102)
8. Carpenter CL, Ganz PA, Bernstein L. Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat. 2009 ; 116: 387-396
9. Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 2008 ; 113: 1048-1057
10. Habermann TM, Thompson CA, LaPlant BR, et al. Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol. 2009 ; 84: 795-798
11. Porter M, Kolva E, Ahl R, Diefenbach MA. Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation. Complement Ther Med. 2008 ; 16: 318-324
12. Aksu MG, Bozcuk HS, Korcum AF. Effect of complementary and alternative medicine during radiotherapy on radiation toxicity. Support Care Cancer. 2008 ; 16: 415-419
13. Kristoffersen AE, Fonnebo V, Norheim AJ. Use of complementary and alternative medicine among patients: classification criteria determine level of use. J Altern Complement Med. 2008 ; 14: 911-919
14. Shakeel M, Newton JR, Bruce J, Ah-See KW. Use of complementary and alternative medicine by patients attending a head and neck oncology clinic. J Laryngol Otol. 2008 ; 122: 1360-1364
15. Yang C, Chien LY, Tai CJ. Use of complementary and alternative medicine among patients with cancer receiving outpatient chemotherapy in Taiwan. J Altern Complement Med. 2008 ; 14: 413-416 (Pubitemid 351693511)
16. Cho WC, Chen HY. Clinical efficacy of traditional Chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancer Invest. 2009 ; 27: 334-344
17. Liu C, Liu L, Li P. A survey of researches on synergy and toxicity abatement of traditional Chinese medicine in radiotherapy of nasopharyngeal carcinoma. J Tradit Chin Med. 2001 ; 21: 303-311
18. NCCN Clinical Practice Guidelines in Oncology™. Head and Neck Cancers. v.2.2010. http://www.nccn.org/professionals/physician-gls/PDF/head-and- neck.pdf. Accessed July 24, 2010.
19. Consensus for diagnosis and treatment of Nasopharyngeal Carcinoma (in Chinese). http://www.nhri.org.tw/NHRI-ADM/userfiles/file/tcog/npc.pdf. Accessed July 24, 2010.
20. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med. 2002 ; 162: 281-287 (Pubitemid 34127405)
21. Stein KD, Kaw C, Crammer C, Gansler T. The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 2009 ; 115 (18, suppl). 4397-4408
22. Ritvo P, Irvine J, Katz J, Matthew A, Sacamano J, Shaw BF. The patient's motivation in seeking complementary therapies. Patient Educ Couns. 1999 ; 38: 161-165 (Pubitemid 29430209)
23. Mao JJ, Palmer SC, Straton JB, et al. Cancer survivors with unmet needs were more likely to use complementary and alternative medicine. J Cancer Surviv. 2008 ; 2: 116-124
24. Humpel N, Jones SC. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care (Engl). 2006 ; 15: 362-368 (Pubitemid 44359399)
25. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999 ; 340: 1733-1739 (Pubitemid 29252602)
26. Astin JA, Pelletier KR, Marie A, Haskell WL. Complementary and alternative medicine use among elderly persons: one-year analysis of a Blue Shield Medicare supplement. J Gerontol A Biol Sci Med Sci. 2000 ; 55: M4 - M9
27. Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998 ; 279: 1548-1553 (Pubitemid 28233010)
28. Why people use complementary or alternative therapies. http://www.cancerhelp.org.uk/about-cancer/treatment/complementary-alternative/ about/why-people-use-complementary-or-alternative-therapies. Accessed October 31, 2010.
29. Department of Health. Statistical annual report of medical care, national health insurance, 2007. http://www.doh.gov.tw/statistic/english/5-3/2007.rar. Accessed February 22, 2010.
30. Chang LC, Huang N, Chou YJ, Lee CH, Kao FY, Huang YT. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv Res. 2008 ; 8: 170
31. Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood). 2003 ; 22: 61-76
32. Bureau of National Health Insurance. http://www.nhi.gov.tw/english/index. asp. Accessed July 24, 2010.
33. National Health Insurance Research Database. http://w3.nhri.org.tw/nhird/ /en/index.htm. Accessed October 31, 2010.
34. Barlow WE. Overview of methods to estimate the medical costs of cancer. Med Care. 2009 ; 47 (7, suppl 1). S33 - S36
35. Kupper LL, Karon JM, Kleinbaum DG, Morgenstern H, Lewis DK. Matching in epidemiologic studies: validity and efficiency considerations. Biometrics. 1981 ; 37: 271-291
36. Karon JM, Kupper LL. In defense of matching. Am J Epidemiol. 1982 ; 116: 852-866 (Pubitemid 13244210)
37. Consumer Price Index in Taiwan. http://www.dgbas.gov.tw/public/data/ dgbas03/bs3/inquire/cpispl.xls. Accessed July 24, 2010.
38. International Monetary Fund Web site. http://www.imf.org/external/pubs/ ft/weo/2009/02/weodata/weorept.aspx?sy=1997&ey=2008&scsm=1&ssd= 1&sort=country&ds=.&br=1&c=528%2C111&s=PPPEX%2CPCPI&grp= 0&a=&pr.x=49.pr.y=13. Accessed July 24, 2010.
39. Shih YC, Pan IW, Tsai YW. Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan. Pharmacoeconomics. 2009 ; 27: 947-961
40. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007 ; 17: 584-590 (Pubitemid 47096709)
41. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000 ; 53: 1258-1267 (Pubitemid 32007842)
42. Klabunde CN, Harlan LC, Warren JL. Data sources for measuring comorbidity: a comparison of hospital records and Medicare claims for cancer patients. Med Care. 2006 ; 44: 921-928 (Pubitemid 44454569)
43. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002 ; 40 (8, suppl). IV-26-35
44. Cameron C, Trivedi PK. Econometric models based on count data: comparisons and applications of some estimators and tests. J Applied Econometrics. 1986 ; 1: 29-53
45. Basu A, Manning WG, Mullahy J. Comparing alternative models: log vs Cox proportional hazard?. Health Econ. 2004 ; 13: 749-765 (Pubitemid 39136901)
46. Hsieh SC, Lai JN, Lee CF, Hu FC, Tseng WL, Wang JD. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiol Drug Saf. 2008 ; 17: 609-619
47. Yeh HY, Chen YC, Chen FP, Chou LF, Chen TJ, Hwang SJ. Use of traditional Chinese medicine among pregnant women in Taiwan. Int J Gynaecol Obstet. 2009 ; 107: 147-150
48. Lin HC, Yang WC, Lee HC. Traditional Chinese medicine usage among schizophrenia patients. Complement Ther Med. 2008 ; 16: 336-342
49. Chen FP, Kung YY, Chen YC, et al. Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan. J Ethnopharmacol. 2008 ; 117: 84-91
50. Lai MN, Wang SM, Chen PC, Chen YY, Wang JD. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst. 2010 ; 102: 179-186
51. Lin Y-H, Chen K-K, Chiu J-H. Prevalence, patterns, and costs of Chinese medicine use among prostate cancer patients: a population-based study in Taiwan. Integr Cancer Ther. 2010 ; 9: 16-23
52. Delanian S, Lefaix JL. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol. 2007 ; 17: 99-107 (Pubitemid 46476864)
53. Lang EV, Benotsch EG, Fick LJ, et al. Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial. Lancet. 2000 ; 355: 1486-1490 (Pubitemid 30237354)
54. Lang EV, Berbaum KS, Faintuch S, et al. Adjunctive self-hypnotic relaxation for outpatient medical procedures: a prospective randomized trial with women undergoing large core breast biopsy. Pain. 2006 ; 126: 155-164 (Pubitemid 44781354)
55. Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care. 2008 ; 14: 326-334
56. Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc. 2005 ; 104: 157-163 (Pubitemid 44524953)
57. Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. 2010 ; 28: 2565-2570